期刊文献+

健脾化浊中药治疗中心性浆液性脉络膜视网膜病变疗效观察 被引量:3

Observation of Therapeutic Effect on Central Serous Chorioretinopathy with Spleen strengthening and Turbidity-resolving Herbs
下载PDF
导出
摘要 目的:观察健脾化浊中药治疗中心性浆液性脉络膜视网膜病变的临床疗效。方法:将60例(60眼)中心性浆液性脉络膜视网膜病变患者随机分成2组各30例,对照组应用施图伦、维生素等常规治疗;治疗组在对照组治疗的基础上加健脾化浊中药口服,15天为1疗程,2组均治疗2~4疗程,观察比较2组临床疗效。结果:总有效率治疗组为96.7%,对照组为80.0%,2组比较,差异有显著性意义(P<0.05)。结论:健脾化浊中药联合西药治疗中心性浆液性脉络膜视网膜病变有较好疗效。 objective. To observe the clinical effects of treatment of central serous chorioretinopathy (CSC) with spleen-strengthening and turbidity-resolving herbs. Methods. Sixty CSC patients(involving 60 eyes) were randomly divided into two groups. The control group(n=30) was treated with oral use of vita- mins, and Esculin and Digitalisglycosides Eye Drops. The treatment group(n=30) was treated with oral use of the decoction of spleen-strengthening and turbidity-resolving herbs on the basis of treatment for the control group. Fifteen days constituted one treatment course, and the treatment lasted 2-4 courses. The clinical effects were evaluated after treatment, Results: The total effective rate was 96,7% in the treat- ment group and 80.0% in the control group, the difference being significant (P 〈 0.05). Conclusion: Spleen-strengthening and turbidity-resolving herbs combined with western medicine have certain clinical effect on central serous chorioretinopathy.
机构地区 正定县人民医院
出处 《新中医》 CAS 2013年第5期89-91,共3页 New Chinese Medicine
关键词 中心性浆液性脉络膜视网膜病变(CSC) 中西医结合疗法 健脾化浊 Central serous chorioretinopathy TCM-WM therapy Strengthening Spleen and Resolv- ing Turbidity
  • 相关文献

参考文献3

  • 1李凤呜.眼科全书[M].北京:人民卫生出版社,1996:3248
  • 2.中药新药临床研究指导原则:第3辑[S].[S].中华人民共和国卫生部,1997.50-51.
  • 3王正品,李佃贵,杜艳茹,王彦刚,张纨,刘启泉,贾娟娟,房家毅,郭启云,张建中,郭明州.浊毒致病论与现代中医病因学[J].中医杂志,2010,51(1):11-13. 被引量:151

二级参考文献7

共引文献232

同被引文献11

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部